The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis

Jun Liu20 enrolled

Overview

The aim of our study is to investigate the efficacy and mechanism in fecal microbiota transplantation in the treatment of ulcerative colitis. About 20 Ulcerative Colitis (UC) patients will be recruited into our trial for Fecal Microbiota Transplantation (FMT) treatment,the safety and efficacy of FMT will be observed.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Ulcerative Colitis Fecal Microbiota Transplantation

Interventions

Fecal Microbiota TransplantationBIOLOGICAL

Eligibility

Sex: MALEMin age: 25 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * mild to moderate UC patients * male * volunteered to our FMT trial Exclusion Criteria: * severe UC * Hb \< 6g/dL

Outcomes

Primary Outcomes

Change of mayo criteria in UC patients after FMT.

Time frame: one year

Number of patients with adverse events after FMT.

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.